Business News • PR NewsWire • Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

NEW YORK, Oct. 31, 2012 /PRNewswire-FirstCall/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and...

View More : http://www.prnewswire.com/news-releases/gastrointestinal-disorders-therapeutics-market-to-2018---novel-agents-targeting-...

Releted News by prnewswire

Celebrating Best-in-Class Industry Innovators at Frost & Sullivan Growth Excellence Awards Banquet

Ambev Reports 2012 Third Quarter Results Under IFRS

Cachet Financial Provides Mobile Check Capture for PreCash

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

CIRI's Redesigned Publications Will Engage the Investor Relations Community